Does Interact with other Medications?

Severe Interactions

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • SYMPATHOMIMETICS (INDIRECT & MIXED ACTING)/MAOIS
  • WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>40MG)
  • Serious Interactions

    These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • ASPARTAME; PHENYLALANINE; TYROSINE/NITISINONE
  • MIXED;INDIRECT SYMPATHOMIMETICS/SELECTED MAOIS
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
  • WEAK CYP3A4 INHIBITORS/LONAFARNIB
  • CYP3A4 INDUCERS/LUMATEPERONE
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/ORAL LEFAMULIN
  • WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
  • SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
  • SELECTED INHIBITORS OF P-GP OR BCRP/PAZOPANIB
  • WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30MG OR <=40MG)
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
  • SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
  • Moderate Interactions

    These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
  • MODERATE AND WEAK CYP3A4 INDUCERS/UBROGEPANT
  • WEAK CYP3A4 INHIBITORS/UBROGEPANT
  • WEAK CYP3A4 INHIBITORS/LEMBOREXANT
  • WEAK CYP3A4 INHIBITORS/TACROLIMUS
  • SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
  • SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
  • SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
  • SELECTED MODERATE-WEAK CYP3A4 INDUCERS/EXEMESTANE
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
  • WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
  • GINKGO BILOBA/MIDAZOLAM
  • GINKGO BILOBA/TOLBUTAMIDE
  • CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
  • Drug Survey

    Have you ever purchased cholin-glut-carnit-pidolic-tyr-deanol-dha-151h oral?

    This survey is being conducted by the WebMD marketing sciences department.

    Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

    CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.